Odds ratios varied from 0.18 for family psychoeducation alone to 0.63 for community-based interventions involving family
THURSDAY, Feb. 24, 2022 (HealthDay News) — Almost all family intervention models can prevent relapse in schizophrenia, according to a systematic review and meta-analysis published in the March issue of The Lancet Psychiatry.
Alessandro Rodolico, M.D., from the University of Catania in Italy, and colleagues conducted a systematic review and network meta-analysis to examine family intervention models aimed at preventing relapse in patients with schizophrenia. Eleven family intervention models tested via a total of 90 randomized controlled trials with 10,340 participants were compared in the network meta-analysis.
The researchers found that with the exception of crisis-oriented interventions and family psychoeducation with two sessions or fewer, compared with treatment as usual, all interventions reduced the rate of relapse significantly at the primary time point of 12 months. Compared with treatment as usual, the odds ratios varied from 0.18 to 0.63 for family psychoeducation alone and community-based interventions involving family members, respectively. In various sensitivity and subgroup analyses, the results were robust. For different comparisons, the confidence in the estimates ranged from moderate to very low.
“These findings should be taken into consideration for future clinical guidelines,” the authors write. “In particular, in the context of limited resources, family psychoeducation alone should be offered as a simple but highly effective tool.”
Several authors disclosed financial ties to the biopharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Nighttime Light Exposure Linked to Sleep Parameters in Schizophrenia
Family History of CRC Increases CRC Risk Similarly in IBD, General Population
Psychiatrists Only Agree 55 Percent of the Time on Diagnoses
Brain Abnormalities Identified in Children at Risk for Schizophrenia
PET/MRI Offers Diagnostic, Prognostic Value in Pediatric Epilepsy
Cortical Atrophy in Early-Onset Alzheimer Disease Signature Can Predict Progression to Dementia
Systemic Physical Multimorbidity Higher With Schizophrenia-Spectrum, Bipolar Disorder
Imaging Turnaround Time Increased From 2023 to 2024